| Product Code: ETC6355415 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium`s import of hemostatic agents continued to show strong growth, with key exporting countries including Germany, Netherlands, Finland, China, and the USA. The market witnessed a shift from high concentration in 2023 to a more moderate concentration in 2024, indicating a more diversified import market. With a notable CAGR of 11.9% from 2020 to 2024 and a growth rate of 13.2% from 2023 to 2024, the hemostatic agents sector in Belgium is experiencing steady expansion and a dynamic competitive landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Hemostatic Agents Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Hemostatic Agents Market - Industry Life Cycle |
3.4 Belgium Hemostatic Agents Market - Porter's Five Forces |
3.5 Belgium Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Belgium Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries and procedures in Belgium |
4.2.2 Rising prevalence of chronic diseases requiring surgical interventions |
4.2.3 Technological advancements in hemostatic agents leading to improved efficacy and safety |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic agents |
4.3.2 High cost associated with advanced hemostatic agents |
4.3.3 Limited awareness and adoption of hemostatic agents among healthcare professionals |
5 Belgium Hemostatic Agents Market Trends |
6 Belgium Hemostatic Agents Market, By Types |
6.1 Belgium Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Belgium Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Belgium Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Belgium Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Belgium Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Belgium Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Belgium Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Belgium Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Belgium Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Belgium Hemostatic Agents Market Export to Major Countries |
7.2 Belgium Hemostatic Agents Market Imports from Major Countries |
8 Belgium Hemostatic Agents Market Key Performance Indicators |
8.1 Rate of adoption of advanced hemostatic agents in surgical procedures |
8.2 Number of research and development activities focused on enhancing hemostatic agents |
8.3 Patient outcomes and reduction in post-operative complications due to the use of hemostatic agents |
9 Belgium Hemostatic Agents Market - Opportunity Assessment |
9.1 Belgium Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Belgium Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Hemostatic Agents Market - Competitive Landscape |
10.1 Belgium Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Belgium Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |